化疗是缓解晚期恶性肿熠症状,减轻病人痛苦,延长病人生命的重要措施,但化疗药物常抑制造血系统功能,化疗后继发白细胞减少症在临床上相当常见。这往往使化疗过程中断或延长,且易发生难治性感染,影响化疗效果。我们借鉴于近年来国内外开展的胎肝细胞输注(FLCT)治疗再生障碍性贫血(再障)、重症肝炎和免疫缺陷性疾病的经验,于1988年5月至1988年8月应用FLCT治疗晚期恶性肿瘤化疗后白细胞减少症19例,初步观察取得了一定疗效,现报告如下: Chemotherapy is an important measure to relieve the symptoms of advanced malignant swollen glimpse, relieve the suffering of patients and prolong the life of patients. However, chemotherapeutic drugs often inhibit the function of hematopoietic system. Secondary leucopenia after chemotherapy is quite common clinically. This often interrupts or prolongs the course of chemotherapy and is refractory to infection, affecting the efficacy of chemotherapy. Drawing on the experience of Fetal Liver Cell Infusion (FLCT) treatment of aplastic anemia (aplastic anemia), severe hepatitis and immunodeficiency diseases both at home and abroad in recent years, we applied FLCT from May 1988 to August 1988 19 cases of advanced malignant neutropenia after chemotherapy, preliminary observation and achieved some curative effect, are as follows: